South Korea bans Crypto, Ethereum hit an all time high. MoneyGram and Ripple team up. Arizona considers letting residents pay taxes with digital currency. John Detrixhe, future of finance reporter at Quartz weighs in on all the latest headlines. South Korea is planning to put a ban on trading virtual currency in the nation. The new causing Bitcoin to drop. A new bill submitted to the Arizona Senate could allow people to pay taxes with crypto. The bill, introduced Tuesday, has been referred to the Arizona Senate Rules Committee for further deliberation. A similar effort was undertaken in New Hampshire in 2016. But concern over bitcoin's volatile price ultimately led to the bill's failure. John Detrixhe, future of finance reporter at Quartz takes a look at the top hubs for cryptocurrency. Including Moscow, Silicon Valley, New York and London.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More